Investigation preoperative seroprevalence of HBsAg, anti-HBS, anti-HCV, anti-HIV and vaccination level of patients undergoing dental surgical procedure under local anesthesia
Investigation preoperative seroprevalence of HBsAg, anti-HBS, anti-HCV, anti-HIV and vaccination level of patients undergoing dental surgical procedure under local anesthesia
Aim: Health care workers especially dentists are at risk due to the fact that they are in direct contact with the blood and body fluids.In the present study, it was aimed to determine the preoperative seropositivity of HBsAG, anti-HBs, anti-HCV, and anti-HIV in thepatients undergoing dental surgical procedure under local anesthesia.Material and Methods: 1598 patients who were admitted to Department of Oral and Maxillofacial Surgery between 2017-2018 andunderwent surgical intervention for various reasons were included. Demographic data and serum samples taken preoperativelyfrom patients were retrospectively evaluated in terms of HBsAg, Anti-HBs, Anti-HCV and Anti-HIV seropositivity by using archiverecords. Furthermore, the vocational and educational status of the HBsAg (+) patients in addition their awareness about hepatitiswere investigated.Results: Of the 1598 patients, 591 (37%) were males; 1007 (63%) were females. The total number of patients with HBV carriers was73 (4.6%), the number of anti-HBs-positive patients was 828 (51.8%), and the number of anti-HCV-positive patients was 3 (0.19%).Anti-HIV positivity has been observed in none of the patients. When evaluated according to the age ranges, HBsAg was mostlydetected positive in the age ranges of 21-30 and 30-40; when evaluated according to sex, HBsAg was detected higher in women.Conclusions: Knowing the prevalence of infectious diseases is highly important for both the prevention and early diagnosis ofthese diseases. Besides, knowing the seropositivity of these diseases before surgical interventions will facilitate for both oral andmaxillofacial surgeons and other health care personnel to take necessary safety precautions against disease transmission. For thispurpose, although it was observed in our study that the preoperative HBsAg, anti-HBs, anti-HCV and anti-HIV seroprevalence werenot higher than those in the population were, all health care workers should be trained in occupational diseases, vaccinated andfollowed up at regular intervals.
___
- 1. Dong Y, Qiu C, Xia X, et al. Hepatitis B virus and hepatitis C
virus infection among HIV-1-infected injection drug users
- in Dali, China: prevalence and infection status in a crosssectional
study. Arch Virol 2015;160:929-36.
- 2. Zoulim F, Perrillo R. Hepatitis B. Reflections on the current
approach to antiviral therapy. J Hepatol 2008;48:2-19.
- 3. Turhanoğlu M, Onur A, Bilman FB, et al. Eight-year
seroprevalence of HBV, HCV and HIV in Diyarbakir training
and research hospital. Int J Med Sci 2013;10:1595-601.
- 4. Akpınar O, Akpınar H. Preoperative Seroprevalence of HBsAg,
Anti-HCV, Anti-HIV in patient with dental surgery under
general anesthesia. SDU The J Health Sci 2018;9:37-41.
- 5. UNAIDS: Aids by the numbers 2016. https://www.unaids.
org/sites/default/files/media_asset/global-AIDSupdate-
2016_en.pdf access date 25.07.2019
- 6. World Health Organization. Global Hepatitis
Report, 2017. http://apps.who.int/iris/bitstre
am/10665/255016/1/9789241565455-eng.pdf?ua=1
access date 25.07.2019
- 7. Hosoglu S, Akalin S, Sunbul M, et al. Occupational Infections
study g healthcare workerse compliance with universal
precautions in Turkey. Med Hypotheses 2011;77:1079-82.
- 8. Moro PL, Moore A, Balcacer P, et al. Epidemiology of
needlesticks and other sharps injuries and injection safety
practices in the Dominican Republic. Am J Infect Control
2007;35:552-9.
- 9. Gooch BF, Siew C, Cleveland JL, et al. Occupational blood
exposure and HIV infection among oral and maxillofacial
surgeons. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
1998;85:128-34.
- 10. Nagao Y, Matsuoka H, Kawaguchi T, et al. HBV and HCV
infection in Japanese dental care workers. Int J Mol Med
2008;21:791-9.
- 11. Kashyap B, Tiwari U, Prakash A. Hepatitis B virus transmission
and health care workers: epidemiology, pathogenesis and
diagnosis. Ind J Med Special 2018;9:30-5.
- 12. Martins AM, Barreto SM. Hepatitis B vaccination among
dentists surgeons. Rev Saude Publica 2003;37:333-8.
- 13. Ahmad Akhoundi MS, Momeni N, Norouzi M, et al.
Prevalence of blood-borne viruses among Iranian dentists:
Results of a national survey. Int J Occup Med Environ Health
2015;28:593-602.
- 14. Thomas DL, Gruninger SE, Siew C, et al. Occupational risk
of hepatitis C infections among general dentists and oral
surgeons in North America. Am J Med 1996;100:41-5.
- 15. Al-Amad S. Prevalence of hepatitis B, C, and HIV among
patients attending a teaching dental hospital. A 7-year
retrospective study from the United Arab Emirates. Saudi
Med J 2018;39:500-5.
- 16. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009.
Hepatology 2009;50:661-2.
- 17. Delialioglu N, Ozturk C, Aslan G. Seroprevalence of HBsAg,
Anti-HBs, Anti-HCV and Anti-HDV in Mersin. Viral Hepat J
2001:7;416-9.
- 18. Uzun B, Gungor S, Demirci M. Seroprevalence of transfusion
transmissible infections among blood donors in western
part of Turkey: a six-year study. Transfus Apher Sci
2013;49:511-5.
- 19. Tozun N, Ozdogan O, Cakaloglu Y, et al. Seroprevalence
of hepatitis B and C virus infections andrisk factors in
Turkey: a fieldwork TURHEP study. Clin Microbiol Infect
2015;21:1020-6.
- 20. Igde FA, Taskin H, Igde M, et al. Where we are in the fight
against Hepatitis B Infection; Trends in Hepatitis B virus
seroprevalence in Black Sea Region of Turkey. Niger J Clin
Pract 2018;21:87-92.
- 21. Onerci Celebi O, Araz Server E, Hamit B, et al. The
seroprevalence of hepatitis B, hepatitis C, and human
immunodeficiency virus in patients undergoing septoplasty.
Braz J Otorhinolaryngol 2018;84:34-9.
- 22. Dilek I, Demir C, Bay A, et al. Seropositivity rates of HBsAg,
anti-HCV, anti-HIV and VDRL in blood donors in Eastern
Turkey. Turk J Haematol 2007;24:4-7.
- 23. Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global
epidemiology of hepatitis C virus infection: new estimates of
age-specific antibody to HCV seroprevalence. Hepatology
2013;57:1333-42.
- 24. UNAIDS. Gap Report 2014. http://files.unaids.
org/en/media/unaids/contentassets/documents/
unaidspublication/2014/UNAIDS_Gap_report_en.pdf
access date 25.07.2019
- 25. T.C Sağlık Bakanlığı. Türkiye Halk Sağlığı Kurumu Bulaşıcı
Hastalıklar Daire Başkanlığı Zührevi Hastalıklar Birimi.
HIV-AIDS istatistik. https://hsgm.saglik.gov.tr/tr/bulasicihastaliklar/
862-hiv-aids/1135-h%C4%B1v-aids-istatislik.
html access date 25.07.2019